MHRA Offers Roadmap for Reporting Drug Defects

Drug Industry Daily
The UK’s Medicines and Healthcare products Regulatory Agency (MRHA) is reminding drugmakers they must report all defects in medicinal products that could lead to a recall immediately upon discovery and provide regular updates on internal investigations into the defects.

To View This Article:


Subscribe To Drug Industry Daily